Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase IIIb trial evaluates Integrilin in early use acute coronary syndrome setting

June 4, 2004

Second successful clinical study with VR-004 for erectile dysfunction

June 4, 2004

First success-based milestone in Syrrx and Biogen Idec collaboration

June 4, 2004

Bimosiamose attenuates LAR in mild allergic asthma

June 4, 2004

Oral rhLF reduces the effects of allergen challenge in a sheep model of asthma

June 4, 2004

Bone Care International highlights third quarter progress

June 4, 2004

Caspase-3 inhibitor improves islet graft functions

June 4, 2004

New COX-2 inhibitors prepared and tested by Korean team

June 3, 2004

Merck KGaA patent covers new factor Xa and factor VIIa inhibitors

June 3, 2004

Novel macrocyclic lactam with antimicrobial and antitumor activity

June 3, 2004

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...